Robin Friedman
@robinfriedman.bsky.social
Computational biologist in industry; views are my own. Wide interests in genomics, immunotherapy, pharmacology, biotech, single cell methods, and reproductive biology.
If true, that has implications for how western biotech can compete. I'm not holding my breath for a change in the regulatory regime to rescue us.
May 3, 2025 at 1:18 PM
If true, that has implications for how western biotech can compete. I'm not holding my breath for a change in the regulatory regime to rescue us.
1. Scale. I'm sure China's huge population helps with trial enrollment across many indications
2. Cost. If research costs are 4x lower, you can place 4x the number of bets and/or throw more people and experiments at problems to accelerate timelines.
2. Cost. If research costs are 4x lower, you can place 4x the number of bets and/or throw more people and experiments at problems to accelerate timelines.
May 3, 2025 at 1:16 PM
1. Scale. I'm sure China's huge population helps with trial enrollment across many indications
2. Cost. If research costs are 4x lower, you can place 4x the number of bets and/or throw more people and experiments at problems to accelerate timelines.
2. Cost. If research costs are 4x lower, you can place 4x the number of bets and/or throw more people and experiments at problems to accelerate timelines.
Haven't seen anything saying it's a lower bar than Australia, for example. Instead, low visibility into the Chinese biotech ecosystem probably contributed to the perception of fast clinical data. Other factors seem more important:
May 3, 2025 at 1:16 PM
Haven't seen anything saying it's a lower bar than Australia, for example. Instead, low visibility into the Chinese biotech ecosystem probably contributed to the perception of fast clinical data. Other factors seem more important:
Strange, works now for me. Thanks for posting!
April 25, 2025 at 1:14 PM
Strange, works now for me. Thanks for posting!
Looks like the Asimov Press link is broken?
April 25, 2025 at 2:27 AM
Looks like the Asimov Press link is broken?